Amphastar Pharmaceuticals (AMPH) Inventory (2013 - 2026)

Amphastar Pharmaceuticals has reported Inventory for 14 years, with the latest figure at $179.9 million in Q2 2026.

• On a quarterly basis, Inventory fell 6.17% year-over-year to $179.9 million in Q2 2026; TTM through Jun 2026 was $179.9 million, a 6.17% decrease from a year earlier, with the FY2025 full-year figure at $176.9 million, up 15.06% from the prior year.
• Inventory was $179.9 million for Q2 2026 at Amphastar Pharmaceuticals, up from $170.2 million in the prior quarter.
• The five-year high for Inventory was $191.7 million in Q2 2025, with the low at $95.1 million in Q1 2022.
• Average Inventory over 5 years is $135.4 million, with a median of $119.0 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Inventory jumped 60.59% in 2025, then decreased 8.24% in 2026.
• Over 5 years, Inventory stood at $103.6 million in 2022, then advanced by 2.17% to $105.8 million in 2023, then jumped by 45.27% to $153.7 million in 2024, then rose by 15.06% to $176.9 million in 2025, then grew by 1.71% to $179.9 million in 2026.
• The last three Inventory figures came in at $179.9 million (Q2 2026), $170.2 million (Q1 2026), and $176.9 million (Q4 2025), per Business Quant data.